Cornell University researchers report they have discovered direct genetic evidence that a family of genes, called MicroRNA-34 (miR-34), are bona fide tumor suppressors.

Chemists devise a new way to manufacture peptide drugs, which hold promise for treating many diseases.

Hopkins researchers improve modeling of movement in 3D environments, which could lead to better understanding of how metastasis occurs.

UH researcher says 'Google Flu Trend' shows where 'big data' analysis can go wrong.

The William K. Warren Foundation of Tulsa, Okla., has made a $3.5 million gift to the University of Notre Dame that, combined with a previous gift valued at $6.5 million, will endow the creation of The Warren Family Research Center for Drug Discovery and Development in the College of Science.

Before doctors like Matthias Kretzler can begin using the results of molecular research to treat patients, they need science to find an effective way to match genes with the specific cells involved in disease. As Kretzler explains, finding that link would eventually let physicians create far more effective diagnostic tools and treatments.

For lab manager Mark Lloyd, finding the motivation to come to work every day isn’t difficult. All it takes is an extra-long walk—a routine that started when he was a master’s student working at a shared resource facility at Georgetown University.

Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threatening kidney fibrosis.

A commonly-used HIV drug has been shown to kill-off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial led by The University of Manchester with Kenyatta National Hospital (KNH) in Nairobi.

UC San Francisco’s four professional schools topped the nation in federal research funding in 2013, with the University as a whole ranking first among public recipients and second overall in funds from the National Institutes of Health (NIH), according to annual NIH figures.

A new sweat test for cystic fibrosis developed at Stanford University produces more detailed information than before, which may aid treatment of the disease.

Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease. Scientists have engineered a microchip coated with blood vessel cells to learn more about the conditions under which nanoparticles accumulate in the plaque-filled arteries of patients with atherosclerosis, the underlying cause of myocardial infarction and stroke.